International Conference on Hematology and Red Cell Disorders
(ICHRCD-26)

26th December 2026 || Chandigarh - India || Hybrid Mode

Proudly Organized by INRI

Join global experts to share ideas, connect, and innovate.
🎉 Coupon Copied Successfully!

Conference Session Tracks

The International Conference on Hematology and Red Cell Disorders (ICHRCD), scheduled to be held on 26th December 2026 in Chandigarh, India, features a diverse range of session tracks covering key research areas, emerging trends and interdisciplinary innovations within the field of Hematology.

Each track offers researchers, academicians, industry professionals and practitioners a platform to present their work, exchange ideas and explore the advancements shaping the future of the domain. Every track is curated to encourage knowledge sharing, collaboration and meaningful discussion.

All Session Tracks
  • Track 01 – Advancements in Molecular Diagnostics for Hematological Disorders
    This track will explore the latest innovations in molecular diagnostic techniques for the identification and management of hematological disorders. Emphasis will be placed on the integration of genomic data into clinical practice. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 02 – Clinical Research Innovations in Red Cell Disorders
    This session focuses on recent clinical research findings related to red cell disorders, including anemia and polycythemia. Participants will discuss novel therapeutic approaches and their implications for patient care. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 03 – Patient Monitoring Strategies in Hematology
    This track will address the importance of effective patient monitoring in the management of hematological conditions. Discussions will include the use of technology and biomarkers to enhance patient outcomes. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 04 – Transfusion Therapy: Current Practices and Future Directions
    This session will cover the latest guidelines and practices in transfusion therapy for patients with hematological disorders. The focus will be on safety, efficacy, and emerging alternatives to traditional transfusion methods. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 05 – Laboratory Techniques in Hematology: Innovations and Challenges
    This track will highlight cutting-edge laboratory techniques used in the diagnosis and treatment of hematological disorders. Participants will discuss the challenges faced in implementing these techniques in clinical settings. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 06 – Translational Research in Hematology: Bridging Bench to Bedside
    This session will emphasize the role of translational research in advancing hematology practices. Presentations will focus on how laboratory discoveries are being translated into clinical applications. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 07 – Biomarker Discovery in Hematological Disorders
    This track will explore the identification and validation of biomarkers for hematological disorders. Discussions will include their potential role in diagnosis, prognosis, and treatment response. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 08 – Therapeutic Strategies for Hematological Malignancies
    This session will focus on innovative therapeutic strategies for the treatment of hematological malignancies, including leukemia and lymphoma. Experts will share insights on novel agents and combination therapies. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 09 – Pediatric Hematology: Unique Challenges and Solutions
    This track will address the specific challenges faced in the diagnosis and treatment of hematological disorders in pediatric populations. Emphasis will be placed on tailored therapeutic approaches and long-term management. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 10 – Hematology in the Era of Personalized Medicine
    This session will examine the impact of personalized medicine on the field of hematology. Discussions will focus on how genetic profiling and individualized treatment plans are transforming patient care. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 11 – Global Perspectives on Hematology and Red Cell Disorders
    This track will provide a platform for sharing global insights and experiences in the management of hematological disorders. Participants will discuss disparities in care and strategies for improving outcomes worldwide. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 10 – Reduced Inequalities
Alignment with the Sustainable Development Goals
Alongside its academic focus, the conference promotes responsible research, ethical practice and knowledge-driven development. Its session tracks collectively contribute to the following United Nations Sustainable Development Goals.
  • SDG 3 SDG 3
    Good Health and Well-being
  • SDG 4 SDG 4
    Quality Education
  • SDG 9 SDG 9
    Industry, Innovation and Infrastructure
  • SDG 10 SDG 10
    Reduced Inequalities

Need Assistance?

If you need any clarification on the session tracks or support with your submission, please feel free to reach out to us:

Email: [email protected]

Phone: +91 9677007228